Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility

Date Published07/16/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Generate Life Science
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Reshoring
Year reshoring announced:2021
Domestically, the work will be done:In-house
City reshored to:La Jolla
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshorednewborn stem cell biologics
What domestic positive factors made reshoring more attractive?Higher productivity, Impact on domestic economy, Other, import replacement
Find Reshoring Articles